A collaboration between ENT Specialists at University of Toronto and formulation experts at Micellae Delivery Systems, we have developed a patent-pending fast-acting intranasal composition of cannabidiol (CBD) solubilized in a microemulsion to treat inflammatory conditions of the upper airways.